A case of juvenile pityriasis rubra pilaris type III successfully treated with etanercept

Dermatol Ther. 2018 Jan;31(1). doi: 10.1111/dth.12577. Epub 2017 Nov 28.

Authors

Viviana Lora¹, Catia De Felice², Carlo Cota³, Dario Graceffa², Aldo Morrone¹, Claudio Bonifati²

Affiliations

¹ Department of Clinical Dermatology, San Gallicano Dermatologic Institute, IRCCS, Rome, Italy.
² Center for the Study and Treatment of Psoriasis, San Gallicano Dermatologic Institute, IRCCS, Rome, Italy.
³ Dermatopathological Laboratory, San Gallicano Dermatologic Institute, IRCCS, Rome, Italy.

PMID: 29193567
DOI: 10.1111/dth.12577

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adolescent
Age of Onset
Biopsy
Drug Administration Schedule
Etanercept / administration & dosage*
Humans
Immunosuppressive Agents / administration & dosage*
Injections, Subcutaneous
Male
Pityriasis Rubra Pilaris / diagnosis
Pityriasis Rubra Pilaris / drug therapy*
Pityriasis Rubra Pilaris / immunology
Remission Induction
Skin / drug effects*
Skin / immunology
Skin / pathology
Treatment Outcome
Tumor Necrosis Factor-alpha / antagonists & inhibitors
Tumor Necrosis Factor-alpha / immunology

Substances

Immunosuppressive Agents
Tumor Necrosis Factor-alpha
Etanercept